Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 2,130 shares at $246.54 ($527K) on 2016-02-09, disclosed to the SEC on 2016-02-10.
Open-market sale of $527k BIIB by EVP CMO Neuro & Neurodegenerat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.77 | 426 | $107K | 20.3% |
| 2 | $246.54 | 852 | $210K | 39.9% |
| 3 | $246.54 | 852 | $210K | 39.9% |
| Total | $247.39 avg | 2,130 | $527K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |